The Pelosi-Bloom autotransfuser is a compact, portable medical device using previously FDA-approved components to rapidly transfuse a patient’s own blood during acute bleeding events in operating rooms, cardiac procedure units, ambulances and military medical units. It can be used in place of more expensive cell saver units that can be used only in hospital settings. A strategic marketing plan is needed to determine how this device should go to market.

Assess a limited collection of recycled glass and recommend solutions to increase supply to enable more sustainable manufacturing.

Develop a business case for improvement of an identified operations process.

Create a post-merger integration strategy to share, communicate, and deploy human resource policies and operational processes.